CD163 and dengue disease: Increased sCD163 levels, as a macrophage activation marker, have been reported for human immunodeficiency virus (HIV), dengue, influenza, hepatitis B and C, Epstein–Barr viruses, and measles, to name a few, the clinical value of which has been reported elsewhere [88].